DexCom Inc. (NASDAQ: DXCM) stock closed at 107.71 per share at the end of the most recent trading day (a 0.58% change compared to the prior day closing price) with a volume of 2.85M shares and market capitalization of 41.67B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7000 people. DexCom Inc. CEO is Kevin R. Sayer.

The one-year performance of DexCom Inc. stock is -1.11%, while year-to-date (YTD) performance is -4.88%. DXCM stock has a five-year performance of 652.16%. Its 52-week range is between 66.8925 and 134.765, which gives DXCM stock a 52-week price range ratio of 60.37%

DexCom Inc. currently has a PE ratio of 263.20, a price-to-book (PB) ratio of 24.52, a price-to-sale (PS) ratio of 20.30, a price to cashflow ratio of 72.20, a PEG ratio of 2.32, a ROA of 4.07%, a ROC of 6.08% and a ROE of 10.01%. The company’s profit margin is 11.91%, its EBITDA margin is 15.50%, and its revenue ttm is $2.09 Billion , which makes it $5.42 revenue per share.

Of the last four earnings reports from DexCom Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.26 for the next earnings report. DexCom Inc.’s next earnings report date is 09th Feb 2023.

The consensus rating of Wall Street analysts for DexCom Inc. is Strong Buy (1.33), with a target price of $125, which is +15.94% compared to the current price. The earnings rating for DexCom Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DexCom Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DexCom Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.42, ATR14 : 3.57, CCI20 : -36.51, Chaikin Money Flow : 0.06, MACD : -1.62, Money Flow Index : 54.84, ROC : -0.70, RSI : 47.41, STOCH (14,3) : 67.14, STOCH RSI : 1.00, UO : 63.77, Williams %R : -32.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DexCom Inc. in the last 12-months were: Barbara E. Kahn (Sold 2 766 shares of value $1 219 757 ), Barry J. Regan (Sold 2 212 shares of value $1 106 000 ), Chad Patterson (Sold 3 973 shares of value $1 701 249 ), Jereme M. Sylvain (Sold 3 000 shares of value $451 230 ), Kevin R. Sayer (Sold 55 607 shares of value $8 974 833 ), Matthew Vincent Dolan (Sold 4 377 shares of value $1 857 125 ), Paul R. Flynn (Sold 8 988 shares of value $1 110 018 ), Shelly Ramasamy Selvaraj (Sold 2 366 shares of value $949 405 ), Steven R. Pacelli (Sold 5 574 shares of value $1 051 855 )